Congratulations to all of our physicians here at Fairfield County Allergy, Asthma & Immunology for making “Top Docs” again this year!
Please try to schedule your allergy shot appointments on line. Your best bet might be to go through the “Patient Center” on this web site. The link is towards the top of our home page. Unfortunately, the app for you phone is not dependable.
If you are over due for your injections, please call a day or so in advance to let our nurses know you will be coming back in. They will have time to make sure your the proper vials (right concentration) are prepared before you arrive so you will have a much shorter wait and improve your social distancing.
FCAAIA Notes: So called “alternative” or “complementary” treatments are not necessarily bad. But, they are also not necessarily effective, especially as compared to medications that have under gone rigorous safety and efficacy evaluations before approval by the FDA. Proponents of alternative and complementary medicine often report their successes as anecdotes. But, as a well-known allergist once wrote, “The plural of anecdote is not data.” Whenever someone prescribes an FDA-approved medication or recommends a remedy that is not well studied, it is OK (and usually useful) to ask “Show me the data”. Then you can make an informed emotional decision based on science, not emotion. Continue reading “SHOULD DOCTORS EMBRACE OR REJECT ALTERNATIVE TREATMENTS?”
FCAAIA Notes: Twenty years ago the SMART study suggested a risk of long-acting beta agonists (LABA) use, However, the rail was associated with the use of LABA alone and NOT with the concurrent use of inhaled corticosteroids (ICS). Study after study shows that when used in combination with ICS, LABAs do not increase risk of asthma morbidity or mortality. Of course, the patients who need LABAs along with their ICS have more severe asthma to start with, so their risk is greater than those who do not require LABAs.
An important point is that many patients who use ICS/LABA combinations have never tried and ICS alone. Continue reading “REVISITING THE SAFETY OF LABAS IN CHILDREN WITH SEVERE ASTHMA”